Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects (Oberab).
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Rabeprazole (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Acronyms OBERAB
- 10 May 2011 Results presented at Digestive Disease Week 2011.
- 23 Sep 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 23 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.